Background: Acute pulmonary embolism (PE) is a common and potentially lethal form of venous thromboembolism (VTE) which is commonly encountered in clinical practice. Most patients die of this fatal condition usually within the first 1 h of the event with mortality rate reaching nearly 10% during this period.(1)
Objective: The objective of this study was to determine of risk factors and clinical presentation of acute pulmonary embolism at Sohag University Hospitals
patients& Methods: All the patients underwent the following:
(1) Detailed history was taken. (2) Examination: Full clinical examination. (3) Investigations: (ABG, D. Dimer, CBC, ECG, Echocardiography, and CT Angiography).
Results: As regard risk factors of pulmonary embolism 70% of them have DVT, 42% have dyslipidemia 32% were postoperative, 28% were diabetics, 24% were hypertensive, 22% were smokers and 20% were females taking cocs).
Conclusion: The study show that PE more common in females and the mean age of the studied patients was 45years The most common risk factor is DVT. |
- Belohla´vek J, Dytrych V, Linhart A. Pulmonary embolism. Part I. Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18(Spring (2)): 129–138
- Ansari A. Acute and chronic pulmonary thromboembolism: current perspectives. I. Glossary of terms, historic evolution and prevalence. Clin Cardiol. 2016;9: 398–402
- Worsley DF, Alavi A. Comprehensive analysis of the results of the PIOPED study. Prospective Investigation of Pulmonary Embolism Diagnosis study. J Nucl Med. 2005;36(December (12)):2380–2387
- .Sutton GC, Hall RJC, Kerr IH. Clinical course and late prognosis of treated subacute massive, acute minor, and chronic pulmonary thromboembolism. Br Heart J. 2007;39:1135–1142.
- . MacIntyre D, Banham SW, Moran F. Pulmonary embolism: long-term follow-up. Postgrad Med J. 2012;58:222–225
- Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 2012;326:1240–1245
- Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 2014; 158: 585–593.CrossRefPubMedGoogle Scholar
- Heit JA. The epidemiology of venous thromboembolism in the community. ArteriosclerThrombVasc Biol. 2008;28(3):370–372
- Atichartakarn V, Pathepchotiwong K, Keorochana S, et al. Deep vein thrombosis after hip surgery among Thai. Arch Intern Med. 2008; 148: 1349–1353.CrossRefPubMedGoogle Scholar
- Nordstrom M, Lindblad B, Bergqvist D, et al. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 2015; 232: 155–160.CrossRefPubMedGoogle Scholar
- Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 2015; 125: 1–7.CrossRefPubMedGoogle Scholar
- . Wroblewski BM, Siney P, White R. Seasonal variation in fatal pulmonary embolism after hip arthroplasty. Lancet. 2010; 335: 56.Google Scholar
- Mok CK, Hoaglund FT, Rogoff SM, et al. The incidence of deep vein thrombosis in Hong Kong Chinese after hip surgery for fracture of the proximal femur. Br J Surg. 2016; 66: 640–642.PubMedGoogle Scholar
- Anderson Jr FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmo- nary embolism. The Worcester DVT study. Arch Intern Med. 2012; 151:933–938.
- Goldhaber S, Kessler C, Heit J, et al. Randomized controlled trial of rtPA versus urokinase in the treatment of acute pulmonary embolism. Lancet. 2009;2:293–298
|
